168 related articles for article (PubMed ID: 22945509)
1. Molecular diagnosis of minimal residual disease in head and neck cancer patients.
Graveland AP; Braakhuis BJ; Eerenstein SE; de Bree R; Bloemena E; de Maaker M; van den Brekel MW; Dijk F; Mesker WE; Tanke HJ; Leemans CR; Brakenhoff RH
Cell Oncol (Dordr); 2012 Oct; 35(5):367-75. PubMed ID: 22945509
[TBL] [Abstract][Full Text] [Related]
2. Molecular detection of minimal residual cancer in surgical margins of head and neck cancer patients.
Graveland AP; de Maaker M; Braakhuis BJ; de Bree R; Eerenstein SE; Bloemena E; Leemans CR; Brakenhoff RH
Cell Oncol; 2009; 31(4):317-28. PubMed ID: 19633367
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcription-polymerase chain reaction in bone marrow of head and neck cancer patients.
Colnot DR; Nieuwenhuis EJ; Kuik DJ; Leemans CR; Dijkstra J; Snow GB; van Dongen GA; Brakenhoff RH
Clin Cancer Res; 2004 Dec; 10(23):7827-33. PubMed ID: 15585614
[TBL] [Abstract][Full Text] [Related]
4. Correlation of gene methylation in surgical margin imprints with locoregional recurrence in head and neck squamous cell carcinoma.
Hayashi M; Wu G; Roh JL; Chang X; Li X; Ahn J; Goldsmith M; Khan Z; Bishop J; Zhang Z; Zhou XC; Richmon J; Agrawal N; Koch WM
Cancer; 2015 Jun; 121(12):1957-65. PubMed ID: 25773145
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of molecular alterations in histologically negative surgical margins of head and neck cancer patients.
de Carvalho AC; Kowalski LP; Campos AH; Soares FA; Carvalho AL; Vettore AL
Oral Oncol; 2012 Mar; 48(3):240-8. PubMed ID: 22104250
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnosis of surgical margins and local recurrence in head and neck cancer patients: a prospective study.
van Houten VM; Leemans CR; Kummer JA; Dijkstra J; Kuik DJ; van den Brekel MW; Snow GB; Brakenhoff RH
Clin Cancer Res; 2004 Jun; 10(11):3614-20. PubMed ID: 15173067
[TBL] [Abstract][Full Text] [Related]
7. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of head and neck cancer.
van Houten VM; van den Brekel MW; Denkers F; Colnot DR; Westerga J; van Diest PJ; Snow GB; Brakenhoff RH
Recent Results Cancer Res; 2000; 157():90-106. PubMed ID: 10857164
[TBL] [Abstract][Full Text] [Related]
9. Quantitative molecular detection of minimal residual head and neck cancer in lymph node aspirates.
Nieuwenhuis EJ; Jaspars LH; Castelijns JA; Bakker B; Wishaupt RG; Denkers F; Leemans CR; Snow GB; Brakenhoff RH
Clin Cancer Res; 2003 Feb; 9(2):755-61. PubMed ID: 12576446
[TBL] [Abstract][Full Text] [Related]
10. Tissue imprint for molecular mapping of deep surgical margins in patients with head and neck squamous cell carcinoma.
Roh JL; Westra WH; Califano JA; Sidransky D; Koch WM
Head Neck; 2012 Nov; 34(11):1529-36. PubMed ID: 22223471
[TBL] [Abstract][Full Text] [Related]
11. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer.
van Houten VM; Tabor MP; van den Brekel MW; Kummer JA; Denkers F; Dijkstra J; Leemans R; van der Waal I; Snow GB; Brakenhoff RH
J Pathol; 2002 Dec; 198(4):476-86. PubMed ID: 12434417
[TBL] [Abstract][Full Text] [Related]
12. Analysis of and prognostic information from disseminated tumour cells in bone marrow in primary breast cancer: a prospective observational study.
Falck AK; Bendahl PO; Ingvar C; Isola J; Jönsson PE; Lindblom P; Lövgren K; Rennstam K; Fernö M; Rydén L
BMC Cancer; 2012 Sep; 12():403. PubMed ID: 22963449
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of lymph node-DTCs in patients with node-negative HNSCC.
Sproll C; Freund AK; Hassel A; Hölbling M; Aust V; Storb SH; Handschel J; Teichmann C; Depprich R; Behrens B; Neves RP; Kübler NR; Kaiser P; Baldus SE; Tóth C; Kaisers W; Stoecklein NH
Int J Cancer; 2017 May; 140(9):2112-2124. PubMed ID: 28120418
[TBL] [Abstract][Full Text] [Related]
14. Paired box 5 methylation detection by droplet digital PCR for ultra-sensitive deep surgical margins analysis of head and neck squamous cell carcinoma.
Hayashi M; Guerrero-Preston R; Sidransky D; Koch WM
Cancer Prev Res (Phila); 2015 Nov; 8(11):1017-26. PubMed ID: 26304463
[TBL] [Abstract][Full Text] [Related]
15. Positive frozen section margins predict local recurrence in R0-resected squamous cell carcinoma of the head and neck.
Ettl T; El-Gindi A; Hautmann M; Gosau M; Weber F; Rohrmeier C; Gerken M; Müller S; Reichert T; Klingelhöffer C
Oral Oncol; 2016 Apr; 55():17-23. PubMed ID: 27016013
[TBL] [Abstract][Full Text] [Related]
16. A high-risk 70-gene signature is not associated with the detection of tumor cell dissemination to the bone marrow.
Walter VP; Taran FA; Wallwiener M; Walter C; Grischke EM; Wallwiener D; Brucker SY; Hartkopf AD
Breast Cancer Res Treat; 2018 Jun; 169(2):305-309. PubMed ID: 29374853
[TBL] [Abstract][Full Text] [Related]
17. Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment.
Partridge M; Li SR; Pateromichelakis S; Francis R; Phillips E; Huang XH; Tesfa-Selase F; Langdon JD
Clin Cancer Res; 2000 Jul; 6(7):2718-25. PubMed ID: 10914716
[TBL] [Abstract][Full Text] [Related]
18. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck.
Brennan JA; Mao L; Hruban RH; Boyle JO; Eby YJ; Koch WM; Goodman SN; Sidransky D
N Engl J Med; 1995 Feb; 332(7):429-35. PubMed ID: 7619114
[TBL] [Abstract][Full Text] [Related]
19. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of circulating tumour cells in the bone marrow of patients with SCCHN.
Wollenberg B; Walz A; Kolbow K; Pauli C; Chaubal S; Andratschke M
Onkologie; 2004 Aug; 27(4):358-62. PubMed ID: 15347890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
